Fulgent Genetics (FLGT) EBIT Growth (1y) (2016 - 2026)
Fulgent Genetics (FLGT) EBIT Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -130.92% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 8.57% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 5.49% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 14.55% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 33.00% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -18.11% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 3.63% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 27.44% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 2.57% |
| 10 | Fulgent Genetics | 570.68 Mn | 288.72 Mn | 21.49 Mn | -74.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.90% |
| Dec 31, 2025 | 96.90% |
| Sep 30, 2025 | 10.12% |
| Jun 30, 2025 | -4.27% |
| Mar 31, 2025 | 9.19% |
| Dec 31, 2024 | 89.32% |
| Sep 30, 2024 | -8,080.84% |
| Jun 30, 2024 | 4.51% |
| Mar 31, 2024 | 12.19% |
| Dec 31, 2023 | -18,990.13% |
| Sep 30, 2023 | -39.20% |
| Jun 30, 2023 | -254.74% |
| Mar 31, 2023 | -112.29% |
| Dec 31, 2022 | -99.47% |
| Sep 30, 2022 | -99.78% |
| Jun 30, 2022 | -87.06% |
| Mar 31, 2022 | -24.35% |
| Dec 31, 2021 | -33.22% |
| Sep 30, 2021 | 150.73% |
| Jun 30, 2021 | 3,646.14% |